Molecular Pathogens 2024, Vol.15, No.2, 61-71 http://microbescipublisher.com/index.php/mp 70 Druedahl L., Minssen T., and Price W., 2021, Collaboration in times of crisis: a study on COVID-19 vaccine R&D partnerships, Vaccine, 39: 6291-6295. https://doi.org/10.1016/j.vaccine.2021.08.101 Excler J., Saville M., Berkley S., and Kim J., 2021, Vaccine development for emerging infectious diseases, Nature Medicine, 27: 591-600. https://doi.org/10.1038/s41591-021-01301-0 Farnós O., Gelaye E., Trabelsi K., Bernier A., Subramani K., Kallel H., Yami M., and Kamen A., 2020, Establishing a robust manufacturing platform for recombinant veterinary vaccines: an adenovirus-vector vaccine to control newcastle disease virus infections of poultry in Sub-Saharan Africa, Vaccines, 8(2): 338. https://doi.org/10.3390/vaccines8020338 Fawzy M., Khairy G., Hesham A., Rabaan A., El-Shamy A., and Nagy A., 2021, Nanoparticles as a novel and promising antiviral platform in veterinary medicine, Archives of Virology, 166: 2673-2682. https://doi.org/10.1007/s00705-021-05177-w Files M., Kristjansson K., Rudra J., and Endsley J., 2022, Nanomaterials-based vaccines to target intracellular bacterial pathogens, Frontiers in Microbiology, 13: 1040105. https://doi.org/10.3389/fmicb.2022.1040105 Francis, M., 2020, A Veterinary Vaccine Development Process Map to assist in the development of new vaccines, Vaccine, 38(29): 4512-4515. https://doi.org/10.1016/j.vaccine.2020.05.007 Francis M., 2022, Considerations for rapid development and licencing of conventional and platform technology veterinary vaccines, Avian Pathology, 51: 107-112. https://doi.org/10.1080/03079457.2022.2046703 Fuente J., and Contreras M., 2021, Vaccinomics: a future avenue for vaccine development against emerging pathogens, Expert Review of Vaccines, 20: 1561-1569. https://doi.org/10.1080/14760584.2021.1987222 Gebre M., Brito L., Tostanoski L., Edwards D., Carfi A., and Barouch D., 2021, Novel approaches for vaccine development, Cell, 184: 1589-1603. https://doi.org/10.1016/j.cell.2021.02.030. Gershwin L., and Woolums A., 2020, Veterinary vaccines: current innovations and future trends, Caister Academic Press, pp.238. https://doi.org/10.21775/9781913652593 Le T., Sun C., Chang J., Zhang G., and Yin X., 2022, mRNA vaccine development for emerging animal and zoonotic diseases, Viruses, 14(2): 401. https://doi.org/10.3390/v14020401 Marchi S., Trombetta C., and Montomoli E., 2018, Emerging and re-emerging arboviral diseases as a global health problem, Public Health - Emerging and Re-emerging Issues, 77382. https://doi.org/10.5772/INTECHOPEN.77382 Nachbagauer R., Feser J., Naficy A., Bernstein D., Guptill J., Walter E., Berlanda-Scorza F., Stadlbauer D., Wilson P., Aydillo T., Behzadi M., Bhavsar D., Bliss C., Capuano C., Carreño J., Chromikova V., Claeys C., Coughlan L., Freyn A., Gast C., Javier A., Jiang K., Mariottini C., McMahon M., McNeal M., Solórzano A., Strohmeier S., Sun W., Wielen M., Innis B., García-Sastre A., Palese P., and Krammer F., 2020, A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial, Nature Medicine, 27: 106-114. https://doi.org/10.1038/s41591-020-1118-7 Nicolodi C., Groiss F., Kiselev O., Wolschek M., Seipelt J., and Muster T., 2019, Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.. Vaccine, 37(28): 3722-3729. https://doi.org/10.1016/j.vaccine.2019.05.013. Pagliusi S., Che Y., and Dong S., 2019, The art of partnerships for vaccines, Vaccine, 37: 5909-5919. https://doi.org/10.1016/j.vaccine.2019.07.088. Pagliusi S., Dennehy M., and Kim H., 2018, Vaccines, inspiring innovation in health, Vaccine, 36: 7430-7437. https://doi.org/10.1016/j.vaccine.2018.05.035. Shuja A., Qureshi J., and Shuja N., 2022, Traditional and recent approaches for the development of animal vaccines, a review, Pakistan Journal of Medical and Health Sciences, 16(12): 460. https://doi.org/10.53350/pjmhs20221612460 Thomas L., Bellet C., and Rushton J., 2019, Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology, Vaccine, 37(30): 3974-3980. https://doi.org/10.1016/j.vaccine.2018.10.044 Trovato M., Sartorius R., D’Apice L., Manco R., and Berardinis P., 2020, Viral emerging diseases: challenges in developing vaccination strategies, Frontiers in Immunology, 11: 2130. https://doi.org/10.3389/fimmu.2020.02130
RkJQdWJsaXNoZXIy MjQ4ODYzNA==